Your browser doesn't support javascript.
loading
Guidelines for establishing a 3-D printing biofabrication laboratory.
Sanicola, Henry W; Stewart, Caleb E; Mueller, Michael; Ahmadi, Farzad; Wang, Dadong; Powell, Sean K; Sarkar, Korak; Cutbush, Kenneth; Woodruff, Maria A; Brafman, David A.
Affiliation
  • Sanicola HW; Faculty of Medicine, The University of Queensland, Brisbane 4006, Australia.
  • Stewart CE; Department of Neurosurgery, Louisiana State Health Sciences Center, Shreveport, LA 71103, USA. Electronic address: caleb.stewart@uq.net.au.
  • Mueller M; CSIRO Manufacturing, Clayton, Victoria 3169, Australia.
  • Ahmadi F; Department of Electrical and Computer Engineering, Youngstown State University, Youngstown, OH 44555, USA.
  • Wang D; Quantitative Imaging Research Team, Data61, Commonwealth Scientific and Industrial Research Organization, Marsfield, NSW 2122, Australia.
  • Powell SK; Science and Engineering Faculty, Queensland University of Technology, Brisbane 4029, Australia.
  • Sarkar K; M3D Laboratory, Ochsner Health System, New Orleans, LA 70121, USA.
  • Cutbush K; Faculty of Medicine, The University of Queensland, Brisbane 4006, Australia.
  • Woodruff MA; Science and Engineering Faculty, Queensland University of Technology, Brisbane 4029, Australia. Electronic address: mia.woodruff@qut.edu.au.
  • Brafman DA; School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ 85287, USA. Electronic address: david.brafman@asu.edu.
Biotechnol Adv ; 45: 107652, 2020 12.
Article in En | MEDLINE | ID: mdl-33122013
ABSTRACT
Advanced manufacturing and 3D printing are transformative technologies currently undergoing rapid adoption in healthcare, a traditionally non-manufacturing sector. Recent development in this field, largely enabled by merging different disciplines, has led to important clinical applications from anatomical models to regenerative bioscaffolding and devices. Although much research to-date has focussed on materials, designs, processes, and products, little attention has been given to the design and requirements of facilities for enabling clinically relevant biofabrication solutions. These facilities are critical to overcoming the major hurdles to clinical translation, including solving important issues such as reproducibility, quality control, regulations, and commercialization. To improve process uniformity and ensure consistent development and production, large-scale manufacturing of engineered tissues and organs will require standardized facilities, equipment, qualification processes, automation, and information systems. This review presents current and forward-thinking guidelines to help design biofabrication laboratories engaged in engineering model and tissue constructs for therapeutic and non-therapeutic applications.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bioprinting / Laboratories Type of study: Guideline / Prognostic_studies Language: En Journal: Biotechnol Adv Year: 2020 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bioprinting / Laboratories Type of study: Guideline / Prognostic_studies Language: En Journal: Biotechnol Adv Year: 2020 Document type: Article Affiliation country: Australia